It Takes MSK
MSK 2022 Annual Report
Emeline Aviki, MD, MBA, specializes in surgery to treat gynecologic cancers.
It takes the people of MSK — in every operating room, every lab, every corridor, and every neighborhood — to achieve our mission: Ending cancer for life.
Our three pillars — patient care, scientific research, and education — supported extraordinary progress in 2022. Learn about just some of our achievements in this Annual Report.
It Takes MSK ...
To Believe
Care begins by offering compassion and confidence, to inspire patients as soon as they arrive.
It Takes MSK ...
To Improve Health Equity
We are breaking down barriers to make world-class care available to everyone.
It Takes MSK ...
To Find Treatments for the Toughest Cancers
Teams of experts, from oncologists to nurse practitioners to data analysts, work tirelessly to save the lives of their patients — and those they may never meet.
It Takes MSK ...
To Decode the Most Challenging Mysteries in Science
For 75 years, scientists at the Sloan Kettering Institute have made breakthrough discoveries about why cells turn cancerous, forging new paths for the treatments of tomorrow.
It Takes MSK ...
To Train the Next Generation
Our mission is to help those starting out find their footing.
It Takes MSK Kids ...
To Treat the Whole Child
It Takes MSK ...
To Provide the Best in Nursing Care
The MSK Donor Community
Every year, hundreds of thousands of generous donors do their part to drive more innovation and save more lives. Our patients are grateful, and so are we.
A Message From the President and Chairman
MSK 2022 Annual Report
To view a PDF of the report, click below.
